Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Fabio Scirocchi"'
Autor:
Alain Gelibter, Angela Asquino, Lidia Strigari, Ilaria Grazia Zizzari, Lucrezia Tuosto, Fabio Scirocchi, Angelica Pace, Marco Siringo, Elisa Tramontano, Serena Bianchini, Filippo Bellati, Andrea Botticelli, Donatella Paoli, Daniele Santini, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Immune checkpoint inhibitors (ICIs), administered alone or combined with chemotherapy, are the standard of care in advanced non-oncogene addicted Non-Small Cell Lung Cancer (NSCLC). Despite these treatments' success, most long-ter
Externí odkaz:
https://doaj.org/article/3b1cd664555b4d159dbbfd800c53dc3b
Autor:
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, Ilaria Grazia Zizzari, Agnese Po, Francesca Megiorni, Angela Asquino, Paola Pontecorvi, Hassan Rahimi, Cinzia Marchese, Elisabetta Ferretti, Marianna Nuti, Aurelia Rughetti
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Fibroblast growth factor receptor (FGFR) gene family alterations are found in several cancers, indicating their importance as potential therapeutic targets. The FGFR-tyrosine kinase inhibitor (TKI) pemigatinib has been introduced
Externí odkaz:
https://doaj.org/article/255236c69f6b466e83fed56613c8381c
Autor:
Fabio Scirocchi, Simone Scagnoli, Andrea Botticelli, Alessandra Di Filippo, Chiara Napoletano, Ilaria Grazia Zizzari, Lidia Strigari, Silverio Tomao, Enrico Cortesi, Aurelia Rughetti, Paolo Marchetti, Marianna Nuti
Publikováno v:
EBioMedicine, Vol 79, Iss , Pp 104010- (2022)
Summary: Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) are innovative small target molecules that, in combination with endocrine therapy, have recently been employed in the treatment of patients with HR+/HER2− metastatic breast cance
Externí odkaz:
https://doaj.org/article/91e990b21f784fe680b1ad00938ec62e
Autor:
Alessio Cirillo, Ilaria Grazia Zizzari, Andrea Botticelli, Lidia Strigari, Hassan Rahimi, Simone Scagnoli, Fabio Scirocchi, Angelina Pernazza, Angelica Pace, Bruna Cerbelli, Giulia d’Amati, Paolo Marchetti, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7114 (2023)
Pembrolizumab, an anti-PD-1 antibody, has been approved as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma ((R/M) HNSCC). However, only a minority of patients benefit from immunotherapy, which highlights the nee
Externí odkaz:
https://doaj.org/article/028ed5a7b6ce44e19604a4f1811ac767
Autor:
Fabio Scirocchi, Lidia Strigari, Alessandra Di Filippo, Chiara Napoletano, Angelica Pace, Hassan Rahimi, Andrea Botticelli, Aurelia Rughetti, Marianna Nuti, Ilaria Grazia Zizzari
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14496 (2022)
Blocking the Programmed Cell Death Protein 1 (PD-1)/programmed death ligand-1 (PD-L1) axis has demonstrated great efficacy in cancer immunotherapy treatment and remains the central modality of immune targeting. To support the rational and tailored us
Externí odkaz:
https://doaj.org/article/7f0d79e8e2914d8bb78be3cb3e091a67
Autor:
Fabio Scirocchi, Chiara Napoletano, Angelica Pace, Hassan Rahimi Koshkaki, Alessandra Di Filippo, Ilaria Grazia Zizzari, Marianna Nuti, Aurelia Rughetti
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Cabozantinib (XL-184) is a multitarget tyrosine kinase inhibitor (TKI) targeting receptor tyrosine kinases (RTKs) involved in oncogenesis and angiogenesis. It is currently the standard therapy for medullary thyroid cancer (MTC), metastatic renal cell
Externí odkaz:
https://doaj.org/article/5a02487f09014ddeb2567224fbef96c2
Autor:
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, Ilaria Grazia Zizzari, Luca D’Angelo, Antonio Santoro, Marianna Nuti, Hassan Rahimi, Aurelia Rughetti
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 11, p 6312 (2022)
Despite diagnostic and therapeutic improvements, glioblastoma (GB) remains one of the most threatening brain tumor in adults, underlining the urgent need of new therapeutic targets. Lectins are glycan-binding proteins that regulate several biological
Externí odkaz:
https://doaj.org/article/4e87c65efe1e48719e4c3846df2e91ce
Autor:
Chiara Napoletano, Marianna Nuti, Paolo Marchetti, Aurelia Rughetti, Giulia D'Amati, Giovanni Schinzari, Alain Gelibter, Ernesto Rossi, Francesca Romana Di Pietro, Fabio Scirocchi, Alessio Ugolini, Maria Gemma Pignataro, Emma Rullo, Angelina Pernazza, Lidia Strigari, Andrea Botticelli, Alessandra Di Filippo, Ilaria Grazia Zizzari
Supplementary Table from Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26075ee58ccdb7d56a1c7c101be1dee0
https://doi.org/10.1158/1078-0432.22487157
https://doi.org/10.1158/1078-0432.22487157
Autor:
Chiara Napoletano, Marianna Nuti, Paolo Marchetti, Aurelia Rughetti, Giulia D'Amati, Giovanni Schinzari, Alain Gelibter, Ernesto Rossi, Francesca Romana Di Pietro, Fabio Scirocchi, Alessio Ugolini, Maria Gemma Pignataro, Emma Rullo, Angelina Pernazza, Lidia Strigari, Andrea Botticelli, Alessandra Di Filippo, Ilaria Grazia Zizzari
Supplementary Figure from Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d629773985b8e64f0cab27000e45e52
https://doi.org/10.1158/1078-0432.22487169.v1
https://doi.org/10.1158/1078-0432.22487169.v1
Autor:
Chiara Napoletano, Marianna Nuti, Paolo Marchetti, Aurelia Rughetti, Giulia D'Amati, Giovanni Schinzari, Alain Gelibter, Ernesto Rossi, Francesca Romana Di Pietro, Fabio Scirocchi, Alessio Ugolini, Maria Gemma Pignataro, Emma Rullo, Angelina Pernazza, Lidia Strigari, Andrea Botticelli, Alessandra Di Filippo, Ilaria Grazia Zizzari
Purpose:CD137 molecule is expressed by activated lymphocytes, and in patients with cancer identifies the tumor-reactive T cells. In solid tumors, high levels of circulating CD137+ T cells are associated with the clinical response and the disease-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8f3fb3d67d47f3e7c9c51ff5167c6f
https://doi.org/10.1158/1078-0432.c.6532458.v1
https://doi.org/10.1158/1078-0432.c.6532458.v1